Emdogain: A Magical Periodontal Regeneration Agent or an Overrated Solution?

In recent veterinary dentistry, the concept of “saving natural teeth” has gained increasing attention. A 2025 study reported that periodontal disease is the primary cause of tooth extraction (82.05%) in small- to medium-sized dogs in Korea. Periodontal disease progresses from gingivitis, which is reversible, to periodontitis, which is irreversible and characterized by the destruction of normal periodontal structures. The concept of “saving natural teeth” includes guided tissue regeneration (GTR), a surgical approach that aims to restore these damaged tissues to a normal or near-normal state. Recently, Emdogain has been introduced as a biomaterial capable of simplifying conventional GTR procedures—traditionally involving bone grafts and barrier membranes—while potentially maximizing periodontal regeneration. This lecture will provide an in-depth analysis of Emdogain’s concept, application techniques, limitations, and anticipated clinical outcomes.
Emdogain is a porcine enamel matrix derivative extracted from developing premolars and molars of pigs less than six months old, with amelogenin comprising approximately 90% of its composition. Amelogenin exhibits high morphological conservation across mammalian evolution and can promote the formation of periodontal ligament, cementum, and alveolar bone through mechanisms similar to those involved in root development. Clinical application involves thorough root planing to debride the root surface, conditioning with 24% EDTA (PrefGel) to remove the smear layer, and applying Emdogain to the dried root surface.
However, Emdogain is not universally effective for all periodontal defects. Cases where favorable outcomes are unlikely include: (1) teeth with significant mobility, (2) periodontal pockets involving furcation exposure, and (3) sites with horizontal bone loss. Furthermore, Emdogain application must be performed with surgical access; its use following simple closed root planing is not recommended.
Human studies on Emdogain report varying conclusions, but consistently highlight its ability to accelerate early wound healing, stimulate gingival fibroblast proliferation, and promote partial regeneration of keratinized gingiva. Nonetheless, the sole use of Emdogain in periodontal pockets with extensive defects remains controversial, and its limitations are evident.
This lecture will review the biological mechanisms of Emdogain, detail its surgical application protocol, and discuss clinical case selection criteria. By understanding its mode of action and boundaries, veterinary practitioners can develop case-specific strategies for successful periodontal regeneration.